Loading chat...

US HB7902

Bill

Official Source

Status

Introduced

3/12/2026

Primary Sponsor

Diana Harshbarger

Click for details

Origin

House of Representatives

119th Congress

AI Summary

Legislative Description

To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.

Last Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

3/12/2026

Committee Referrals

Energy And Commerce3/12/2026

Full Bill Text

No bill text available